** Copenhagen-listed shares in Orphazyme ORPHA.CO fall
nearly 30% in morning trade after the Danish drug developer's
U.S. stock ORPH.O tumbled on Friday urn:newsml:reuters.com:*:nL3N2NT33L
** The share price is "adapting" to the U.S. closing price,
Nordnet analysts Per Hansen says
** On Thursday and Friday the company's Copenhagen listed
stock soared in total about 150% -- Hansen says that normally
you would expect the pricing in the U.S. to be reflective of
Danish closing, but this time it was different
** On Friday the company said it was not aware of any
changes in operations that would explain the volatility
urn:newsml:reuters.com:*:nFWN2NT08E
** According to Hansen, Orphazyme became one of meme-stocks,
pointing out it skyrocketed during an extreme trading on
Thursday/Friday
** Including today's losses Orphazyme's Copenhagen-listed
shares are down 20% year to date
((boleslaw.lasocki@tr.com))